FDA Says Drug Safety Monitoring After Approval Has Improved “Significantly”

Federal regulators said that they spend just as much effort and resources on evaluating a drug after it is approved as they do in the pre-approval process, according to an announcement of a report released by the U.S. Food and Drug Administration on Saturday. The “Advances in FDA’s Safety Program for Marketed Drugs” report was in response to critics who say that the agency is powerless when it comes to monitoring the safety of drugs already on the market, when industry funds paying pre-approval drug reviews shrink up.

Click here to read more…

0 Responses to “FDA Says Drug Safety Monitoring After Approval Has Improved “Significantly””



  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 435 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.


%d bloggers like this: